Docking and scoring in virtual screening for drug discovery: methods and applications.

Department of Computer-Aided Drug Discovery, Albany Molecular Research, Inc., 21 Corporate Circle, Albany, New York 12212-5098, USA.
dressNature Reviews Drug Discovery (Impact Factor: 37.23). 12/2004; 3(11):935-49. DOI: 10.1038/nrd1549
Source: PubMed

ABSTRACT Computational approaches that 'dock' small molecules into the structures of macromolecular targets and 'score' their potential complementarity to binding sites are widely used in hit identification and lead optimization. Indeed, there are now a number of drugs whose development was heavily influenced by or based on structure-based design and screening strategies, such as HIV protease inhibitors. Nevertheless, there remain significant challenges in the application of these approaches, in particular in relation to current scoring schemes. Here, we review key concepts and specific features of small-molecule-protein docking methods, highlight selected applications and discuss recent advances that aim to address the acknowledged limitations of established approaches.

  • Molecular Simulation 12/2014; · 1.12 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Toxoplasmosis is a worldwide parasitic infection caused by Toxoplasma gondii that causes life-threatening complications in children and immunocompromised patients. The current treatment of toxoplasmosis involves a limited number of drugs including pyrimethamine, sulfadiazine, clindamycin and spiramycin. Recently, the anti-toxoplasma activity of a novel series of dihydropyrimidine (DHPM) derivatives was reported by our lab. Therefore, the present investigation aimed at optimizing the structure of these derivatives using different techniques of computer-Aided Drug Design (CADD) and discovering novel bicyclic ring systems having potential anti-toxoplasma activity using in silico virtual screening.
    09/2011, Degree: Master of Science, Supervisor: Ibrahim M. Labouta
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Molecular Modeling is essential tool in the drug design process describes the generation, manipulation or representation of 3D structures of the molecules and associated physico-chemical properties while docking predicts the preferred orientation of one molecule to a second when bound to each other to form a stable complex. A cold active lipase producing potential psychrophilic bacteria (GN) was isolated and identified by 16S rRNA molecular studies as Pseudomonas vancouverensis. Lipase gene from closely related species P. fluorescens was investigated for their functional role and in silico characterization using molecular modeling and docking studies. A 3D structure of lipase gene was generated with SWISS-MODEL and Discovery Studio 3.0. The stereochemistry of the constructed model of cold active lipase was subjected to energy minimization and the stereo-chemical quality of the predicted structure was assessed. The superimposition of the template (PDBID: 2Z8X) with predicted structure showed that weighted root mean square deviation of Cα trace between the template and the final refined model was 0.2 Å with a significant Zscore of 8.2 and sequence identity was 80.5%. Three ligands P-Nitrophenol, Acetate ion and Diethyl phosphonate were taken for docking calculation with generated structure. They were interacting on the functional motifs of predicted model. It has been observed that Leu26, Tyr29, Asn31, Asp33, Pro315 and Thr316 residues were involved in hydrogen bonding interactions with selected ligands. So these interacted residues can be used as prominent active binding sites and which was common to the predicted active site. Based on above investigations it has been found that P. vancouverensis lipase protein can play a similar role in lipid metabolic process and triglyceride lipase functional activity as reported for P. fluorescens lipase protein.
    International Journal of Applied Biology and Pharmaceutical Technology 01/2015; 6(1):59-66. · 0.99 Impact Factor


Available from